STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
David A. Tuveson(Cold Spring Harbor Laboratory), George D. Demetri(Dana-Farber Cancer Institute), Christopher D.�M. Fletcher(Brigham and Women's Hospital), Tyler Jacks(Massachusetts Institute of Technology), Samuel Singer(Memorial Sloan Kettering Cancer Center), Nicholas A. Willis(Northern Powergrid (United Kingdom)), Jonathan A. Fletcher(Harvard University), James D. Griffin(Harvard University)
Cited by 700
Related Papers
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
|Nature|2009|4.2k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
|The Journal of Experimental Medicine|2017|2.4k